4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines
CA 2344556 A1 · Owner: Wester, Ronald Thure · Inventors: Ruggeri, Roger Benjamin; Deninno, Michael Paul; Mularski, Christian James
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Cholesteryl ester transfer protein inhibitors of formula (I) pharmaceutical , compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoproteincholesterol and to lower certain other plasma lipid levels such as LDL-, cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDLcholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 10, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 10, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 10, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.